FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Hits Medical Device Intended Use Creep

[ Price : $8.95]

Three Sheppard Mullin attorneys say FDA appears to be focusing on medical device enforcement of device-associated software that is...

Voluntary Consensus Standards Guidance

[ Price : $8.95]

FDA issues a final guidance describing CDERs program for the recognition of voluntary consensus standards related to drug quality....

Octapharma NDA for Warfarin Reverser OKd

[ Price : $8.95]

FDA approves an Octapharma NDA for Balfaxar (prothrombin complex concentrate) for the urgent reversal of acquired coagulation fact...

Abbott Recalls Amplatzer Delivery Sheath

[ Price : $8.95]

Abbott recalls its Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles to be introduced into patients und...

Defender Pharma NDA for Scopolamine Gel

[ Price : $8.95]

Defender Pharmaceuticals files an NDA for its intranasally administered scopolamine gel for preventing motion-caused nausea and vo...

Alert Update on Vessel Occlusion CADt Devices

[ Price : $8.95]

An FDA update clarifies the intended use of radiological computer-aided triage and notification devices for intracranial large ves...

Beckman Coulter Chemistry Analyzer Cleared

[ Price : $8.95]

FDA clears a Beckman Coulter 510(k) for its DxC 500 AU Chemistry Analyzer, an automated analyzer intended for use by small-to-medi...

Stratus Illegally Marketing Biologics: FDA

[ Price : $8.95]

FDA warns Stratus Biosystems that it is illegally marketing biological products whose manufacturing has significant deviations fro...

FDA Denies 2 Vanda Tasimelteon Petitions

[ Price : $8.95]

FDA says the Teva and Apotex generic forms of Vandas Hetlioz do not violate labeling requirements or raise safety concerns due to ...

FDA Approves Eyelid Mite Disease Drug

[ Price : $8.95]

FDA approves a Tarsus Pharmaceuticals NDA for Xdemvy (lotilaner ophthalmic solution) 0.25% for treating Demodex blepharitis, an ey...